yes I’m not really worried about that like other people because you will have unlimited grafts Within 1-2 year we will know if this technology works
I belive the stuck in some serious issue that might consider alot of time to reaserch . And then they reach the point where financily its wasnt worth the risk. But belive me a company that hold the power to restore hair would be one of the world most values company . Its a gold mine . There no limit to the bald people each generation even bald sooner. Tsuji solution is lost . Stemson is our only hope now. The ceo talked about 4-5 years before human clinical trails which mean alot of time
Finasteride can work for years.
ES cells are derived from early human embryos. It's taboo and there is heavy regulation on its use, some American states even outright banned it.
They didn't say it won't be either. So we don't know.
For hyper responder the typical responder is decline after 2 years and thats is FDA based.
Well, you are gloomy. <winks> But facts is facts....
www.longevity.technology
Kyocera has also those abiletis but you need to build the hammer before you punch the nail.Good news for Stemson, this company that is developing a technology to automate and scale the generation of iPS cells just announced a relatively big seed round ($16 million) to develop their tech. Basically, this tech would make the Stemson treatment more cheaper, reliable, and faster.
Cellino closes $16m seed financing
Massachusetts-based biotech announces closing of $16m seed round for stem cell therapy led by The Engine and Khosla Ventures.
Induced Pluripotent Stem Cells (iPSCs) are derived from skin or blood cells that have been reprogrammed so they revert to an embryonic-like pluripotent state; pluripotency enables the cell to develop into any type of human cell, meaning they are fantastic for therapeutic purposes. iPSCs can be triggered to become beta islet cells for diabetes treatment, or neurons for neurological treatment or blood cells, in order to generate new cancer-free blood for leukaemia sufferers.
However, scientists usually have to go through the labour-intensive process of inspecting iPSCs in order to manually weed out ones deemed to be of lower quality. Cellino’s platform could be set to change all that.
Cellino is developing an automated process to generate autologous iPSCs at scale, using machine-learning algorithms to train software to identify both low- and high-quality cells. The software then controls a laser to destroy the unwanted cells. The proprietary platform converges breakthrough technologies across optics, biology and machine learning to engineer high functionality cells with high levels of consistency and yield.
Cellino plans to use this seed financing to scale up this technology, automating and standardising autologous stem cell production, and thereby accelerating the development of life-saving and life-extending therapies for patients.
It would take a lot of the pressure and hard-decision making out of the hair recovery process but probably not the cost.
I think it will be amazing ! Worry about hair loss took a huge shot in mental health of so many ppl. I didnt know that in some point my life would be controld by this shitty gene. I always wonder how my life would be if i had my father genes (thick nw2 age55). Like for real were already in 2021 how balding is still athing.
Same here. Father's 83 and still has grrrr Ronald Reagan hair. My mother wears her hair long at 80 like she always did so so much for genetics. I agree 100 percent about mental health. I wanted to get involved because hair dysphoria is so much like gender dysphoria in general. For me, there really was no separation between hair and gender since in my mind, I was androgynous/non-binary.
Nice find, and great news for us if they decide to collaborate. One of the things keeping me up thinking is how the heck they can cure us all even after the cure is discovered, considering how labor intensive the procedure is.Good news for Stemson, this company that is developing a technology to automate and scale the generation of iPS cells just announced a relatively big seed round ($16 million) to develop their tech. Basically, this tech would make the Stemson treatment more cheaper, reliable, and faster.
Cellino closes $16m seed financing
Massachusetts-based biotech announces closing of $16m seed round for stem cell therapy led by The Engine and Khosla Ventures.
Induced Pluripotent Stem Cells (iPSCs) are derived from skin or blood cells that have been reprogrammed so they revert to an embryonic-like pluripotent state; pluripotency enables the cell to develop into any type of human cell, meaning they are fantastic for therapeutic purposes. iPSCs can be triggered to become beta islet cells for diabetes treatment, or neurons for neurological treatment or blood cells, in order to generate new cancer-free blood for leukaemia sufferers.
However, scientists usually have to go through the labour-intensive process of inspecting iPSCs in order to manually weed out ones deemed to be of lower quality. Cellino’s platform could be set to change all that.
Cellino is developing an automated process to generate autologous iPSCs at scale, using machine-learning algorithms to train software to identify both low- and high-quality cells. The software then controls a laser to destroy the unwanted cells. The proprietary platform converges breakthrough technologies across optics, biology and machine learning to engineer high functionality cells with high levels of consistency and yield.
Cellino plans to use this seed financing to scale up this technology, automating and standardising autologous stem cell production, and thereby accelerating the development of life-saving and life-extending therapies for patients.
When we go in for Covid19 vaccinations, maybe we could pay for an upgrade?
Roll outs are hard!
You mean the webinar being a lie? Lol
Ah, thought it was for the average interested person. Well it's probably too late now.
Doesn't seem like it at this point.